drugset / Trial / NCT04417907

Perampanel Titration and Cognitive Effects

NCT04417907

Phase 4 Terminated 29 enrolled Kimford Jay Meador Eisai Inc. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to determine whether there are any differences in the cognitive abilities and/or behavioral response of normal healthy volunteers across different titration rates of perampanel.

Timeline

Start
2021-10-20
Primary completion
2023-05-01
Completion
2023-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Perampanel Small molecule 4 mg Oral

Indications